Page last updated: 2024-11-02

pentobarbital and Dyspnea

pentobarbital has been researched along with Dyspnea in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Dyspnea: Difficult or labored breathing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gastaud, M1
Dolisi, C1
Camous, JP1
Gibelli, A1
Ripoll, B1
Ardisson, JL1

Other Studies

1 other study available for pentobarbital and Dyspnea

ArticleYear
[Stimulating action on respiration of S2620 in the rabbit anesthetized with pentobarbital].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1974, Volume: 168, Issue:4-5

    Topics: Anesthesia, General; Animals; Blood Pressure; Brain; Chemoreceptor Cells; Dyspnea; Electric Stimulat

1974